acute hepatic porphyrias

Alnylam, with positive data on second gene-silencing drug, plans filing to FDA
Stat
Thu, 09/27/18 - 10:12 am
Alnylam
gene-silencing
givosiran
FDA
acute hepatic porphyrias
Alnylam lines up Phase 3 for another RNAi drug
BioPharma Dive
Tue, 06/27/17 - 10:33 am
Alnylam
RNAi
givosiran
acute hepatic porphyrias